Alexandria Real Estate Equities (NYSE:ARE) Given New $40.00 Price Target at BNP Paribas Exane

Alexandria Real Estate Equities (NYSE:ARE) had its target price reduced by BNP Paribas Exane from $48.00 to $40.00 in a research note released on Tuesday morning. They currently have an underperform rating on the real estate investment trust’s stock.

A number of other research analysts also recently issued reports on ARE. Mizuho decreased their price objective on Alexandria Real Estate Equities from $70.00 to $60.00 and set an “outperform” rating for the company in a report on Monday, July 6th. Evercore reaffirmed an “outperform” rating and set a $59.00 price target on shares of Alexandria Real Estate Equities in a research note on Monday, September 21st. The Goldman Sachs Group boosted their price objective on shares of Alexandria Real Estate Equities from $54.00 to $59.00 and gave the stock a “neutral” rating in a research report on Friday, September 18th. Zacks Research upgraded shares of Alexandria Real Estate Equities from a “strong sell” rating to a “hold” rating in a research note on Wednesday, August 19th. Finally, Morgan Stanley reiterated an “underweight” rating and set a $53.00 target price on shares of Alexandria Real Estate Equities in a report on Thursday, June 11th. Two equities research analysts have rated the stock with a Buy rating, ten have given a Hold rating and four have issued a Sell rating to the stock. According to data from MarketBeat.com, the company has a consensus rating of “Reduce” and a consensus price target of $52.31.

Alexandria Real Estate Equities Stock Down 0.4%

Shares of ARE stock opened at $48.45 on Tuesday. Alexandria Real Estate Equities has a 12-month low of $39.41 and a 12-month high of $85.37. The company has a quick ratio of 0.19, a current ratio of 0.19 and a debt-to-equity ratio of 0.67. The firm has a fifty day moving average of $51.20 and a 200-day moving average of $49.33. The company has a market capitalization of $8.44 billion, a price-to-earnings ratio of -8.00 and a beta of 1.15.

Alexandria Real Estate Equities (NYSE:ARE) last posted its quarterly earnings data on Monday, August 3rd. The real estate investment trust reported ($0.43) EPS for the quarter, missing the consensus estimate of $0.09 by ($0.52). The company had revenue of $662.78 million during the quarter, compared to the consensus estimate of $464.86 million. Alexandria Real Estate Equities had a negative net margin of 36.08% and a negative return on equity of 5.21%. The company’s revenue was down 13.0% compared to the same quarter last year. During the same period in the prior year, the firm posted $2.33 earnings per share. Alexandria Real Estate Equities has set its FY 2026 guidance at 6.350-6.450 EPS. As a group, equities research analysts predict that Alexandria Real Estate Equities will post 6.39 earnings per share for the current fiscal year.

Alexandria Real Estate Equities Dividend Announcement

The business also recently disclosed a quarterly dividend, which will be paid on Thursday, October 15th. Shareholders of record on Wednesday, September 30th will be given a dividend of $0.72 per share. This represents a $2.88 dividend on an annualized basis and a yield of 5.9%. The ex-dividend date of this dividend is Wednesday, September 30th. Alexandria Real Estate Equities’s payout ratio is -47.52%.

Insider Activity

In other Alexandria Real Estate Equities news, EVP Kristina Fukuzaki-Carlson sold 16,810 shares of the stock in a transaction dated Friday, September 11th. The shares were sold at an average price of $50.51, for a total value of $849,073.10. Following the transaction, the executive vice president directly owned 39,152 shares of the company’s stock, valued at $1,977,567.52. This represents a 30.04% decrease in their position. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which is available through this hyperlink. Also, Chairman Joel Marcus acquired 5,000 shares of the business’s stock in a transaction on Friday, September 11th. The shares were bought at an average price of $49.68 per share, with a total value of $248,400.00. Following the completion of the transaction, the chairman directly owned 597,724 shares of the company’s stock, valued at approximately $29,694,928.32. The trade was a 0.84% increase in their ownership of the stock. The disclosure for this purchase is available in the SEC filing. Insiders own 1.35% of the company’s stock.

Hedge Funds Weigh In On Alexandria Real Estate Equities

A number of large investors have recently made changes to their positions in ARE. FNY Investment Advisers LLC acquired a new position in Alexandria Real Estate Equities in the 2nd quarter valued at $26,000. First Bancorp Inc ME acquired a new stake in shares of Alexandria Real Estate Equities during the second quarter worth $26,000. Basecamp Wealth Advisors LLC lifted its holdings in shares of Alexandria Real Estate Equities by 3,723.5% during the first quarter. Basecamp Wealth Advisors LLC now owns 650 shares of the real estate investment trust’s stock worth $30,000 after buying an additional 633 shares in the last quarter. Danske Bank A S bought a new stake in shares of Alexandria Real Estate Equities in the second quarter valued at about $42,000. Finally, SJS Investment Consulting Inc. grew its stake in shares of Alexandria Real Estate Equities by 38.7% in the first quarter. SJS Investment Consulting Inc. now owns 1,150 shares of the real estate investment trust’s stock valued at $53,000 after acquiring an additional 321 shares in the last quarter. Institutional investors own 96.54% of the company’s stock.

About Alexandria Real Estate Equities

Alexandria Real Estate Equities, Inc (NYSE:ARE) is a real estate investment trust focused on owning, operating and developing collaborative life science, agtech and advanced technology campuses. The company provides specialized laboratory, research and office space for organizations involved in biotechnology, pharmaceuticals, medical devices, diagnostics, healthcare and related fields.

Alexandria’s properties are designed to support innovation through purpose-built facilities, shared amenities and environments that encourage collaboration among companies, academic institutions, medical centers and research organizations.